A targeted circulating tumor DNA landscape of copy number aberrations…
Blood-based tumor DNA testing now rivals tissue biopsies at detecting a key aggressive lymphoma risk factor, offering patients a simpler alternative.
- Lab
- Preclinical
- Early trials
- Late trials
- In practice
Enhanced multicancer screening assay through whole-genome methylation…
A blood test combining multiple detection methods catches over 92% of cancers at early stages with very few false alarms, advancing noninvasive screening.
Novel or significantly improved treatmentYAP1 defines an emergent, plastic population of relapsed small cell lung cancer
Researchers identify a treatment-resistant cell type in relapsed lung cancer with specific protein targets, opening new therapeutic possibilities.
Novel or significantly improved treatmentQuadruple pegRNA enables programmable and efficient large genomic insertion
Gene therapy editing now efficiently inserts large DNA fragments into human cells, potentially unlocking treatments for inherited diseases.
Novel or significantly improved treatmentFirst-Line Therapy for Advanced Renal Cell Carcinoma
Combining immunotherapy with targeted drugs works better than dual immunotherapy for advanced kidney cancer, with surprisingly better safety.